期刊文献+

幼年型粒单核细胞白血病的临床和治疗 被引量:9

Clinical characteristics and treatment of juvenile myelomonocytic leukemia
下载PDF
导出
摘要 目的探索幼年型粒单核细胞白血病(JMML)的早期临床、实验室特点,以提高诊断水平和治疗的有效性。方法分析17例JMML患儿的临床特征、外周血常规、单核细胞计数、血涂片,骨髓活检和/或骨髓穿刺的形态学和分子生物学,胎儿血红蛋白(HbF)和病毒抗原检测,诊断及治疗问题。结果17例患儿的年龄分布:2个月~5岁4个月,中位年龄14个月。临床表现:88.2%出现发热、面色苍白、咳嗽,76.5%胸片示支气管肺炎,皮肤出现丘疹58.8%,所有病例肝脾均肿大,其中≥5 cm者占52.9%,淋巴结肿大(浅表和深部)占82.4%。实验室:17例患儿外周血白细胞数中位值32.9×109/L、单核细胞绝对值中位值3.9×109/L,14/17例外周血涂片见髓系前体细胞,中位值28%,7例红系有病态造血,血红蛋白中位值88 g/L,血小板计数中位值33×109/L。骨髓活检和/或骨髓穿刺:原始、早幼粒/原幼单细胞数在5%~20%;14例作骨髓细胞免疫学检测,12例的免疫表型为MPO+、CD117+及其他的髓系标记,2例免疫表型为MPO-、CD14+、CD33+;14例进行细胞遗传分析,其中4例染色体单体改变依次为-8,+8q+、-6,+6q+、-20、-8;分子生物学检测bcr-abl基因阴性。HbF增高(中位值33%),病毒学检测EBV-IgM阳性7例、CMV-IgM阳性6例。结论JMML发病年龄以2岁以内多见,占60%。最初的诊断可类似ITP、病毒感染。JMML有效治疗很少,在缺乏相合供体情况下可选择联合化疗和诱导分化治疗。 Objectives To explore the early clinical and laboratory features of juvenile myelomonocytic leukemia (JMML) to improve accuracy of diagnosis and efficacy of treatment. Methods Seventeen (17) JMML patients were analyzed regarding their clinical features, routine blood test, monocyte count, peripheral blood smear; morphology and molecular biology of bone marrow biopsy and/or aspiration; fetal hemoglobin, virus antigens, accuracy of diagnosis and treatment. Results The age of patients ranges from 2 to 64 months with median of 14 months. In the course of disease, 88.2% of patients had fever, pallor and cough ; 76.5% had bronchial pneumonia; 58.8% had skin rash. Liver and spleen can be palpated in all patients, 52.9% of them with the both organs palpable larger than 5 cm off the coastal of the rib; and 85.7% of patients had enlarged lymph nodes. The median of white blood cell count was 32.9×10^9/L and absolute monocyte count was 3.9 ×10^9/L. Premyeloblast (medium count 28%) was found in 14 out of 17 patients, 7 had abnormal erythropoiesis; the median hemoglobin was 88 g/L and platelet 33×10^9/L. All had bone marrow biopsy and/or aspiration and the counts of myeloblast, premyelocyte and monoblast ranged from 5% to 20%. Twelve of 14 patients expressed MPO^+, CD14^+, CD33^+, while 2 with MPO^-, CD14^+, CD33^+. Cytogenetic analysis showed that 4 out of 14 had chromatid change as -8, +8q+, -6, +6q+. -20, -8. BCR/ABL gene was negative in biological examination. Fetal hemoglobin increased with median of 33%; The EBV-IgM and CMV-IgM were positive in 7 and 6 patients, respectively. Conclusions JMML is common in patients younger than 2 years old. JMML needs to be differentiated from idiopathic thrombopenic purpura and virus infection. There is not much effective treatment for JMML. Combined chemotherapy and differentiation induction might be chosen as a treatment while lacking of matching donors.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2007年第8期648-650,654,共4页 Journal of Clinical Pediatrics
关键词 幼年型粒单核细胞白血病 临床 诊断 治疗 juvenile myelomonocytic leukemia clinical feature diagnosis treatment
  • 相关文献

参考文献14

  • 1Haas OA,Gadner H.Pathogenesis,biology,and management of myelodysplastic syndromes in children[J].Semin Hematol,1996,33 (3):225-235.
  • 2Niemeyer CM,Arico M,Basso G,et al.Chronic myelomonocytic leukemia in childhood:a retrospective analysis of 110 cases.European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)[J].Blood,1997,89 (10):3534-3543.
  • 3张大伟,臧晏,耿兰增,石惠丈,吴敏媛.幼年型粒单核细胞白血病23例临床分析[J].中国小儿血液,2002,7(2):72-74. 被引量:1
  • 4Matsumoto K,Miki J,Matsuzaki S,et al.Skin infiltration of juvenile myelomonocytic leukemia[J].J Dermatol,2004,31 (9):748-751.
  • 5Manabe A,Yoshimasu T,Ebihara Y,et al.Viral infections in juvenile myelomonocytic leukemia:prevalence and clinical implications[J].J Pediatr Hematol Oncol,2004,26(10):636-641.
  • 6Emanuel PD.Juvenile myelomonocytic leukemia[J].Curr Hematol Rep,2004,3 (3):203-209.
  • 7Hall GW.Cytogenetic and molecular genetic aspects of childhood myeloproliferative/myelodysplastic disorders[J].Acta Haematol,2002,108 (4):171-179.
  • 8Corey SJ,Elopre M,Weitman S,et al.Complete remission following clofarabine treatment in refractory juvenile myelomonocytic leukemia[J].J Pediatr Hematol Oncol,2005,27(3):166-168.
  • 9Locatelli F,Nollke P,Zecca M,et al.Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML):results of the EWOGMDS/EBMT trial[J].Blood,2005,105 (1):410-419.
  • 10Koyama M,Nakano T,Takeshita Y,et al.Successful treatment of JMML with related bone marrow transplantation after reduced-intensity conditioning[J].Bone Marrow Transplant,2005,36 (5):453-454.

二级参考文献2

同被引文献75

  • 1郭智,陈惠仁,刘晓东,楼金星,杨凯,陈鹏.单倍型造血干细胞移植治疗幼年型粒单核细胞白血病的临床研究[J].发育医学电子杂志,2014,2(3):150-154. 被引量:6
  • 2Koyama M,Nakano T,Takeshita Y,et al.Successful treatment of JMML with related bone marrow transplantation after reduced-intensity conditioning[J].Bone Marrow Transplant,2005,36(5):45-454.
  • 3Hale H,Olesen G,Kerndrup G,et al.A population-based study of childhood myelodys plastic syndrome in Bristish Columbia,Canada[J].Br J Haematol,1999,106:1027-1032.
  • 4Niemeyer CM,Fenu S,Hasle H,et al.Differentiating juvenile myelomonocytic leukemia from infectious disease[J].Blood,1998,91:365.
  • 5Tefferi A,Vardiman JW.Classification and diagnosis of myeloproliferative neoplasms:The 2008 World Health Organization criteria and point of care diagnostic algorithms[J].Leukemia,2008,22(1):14-22.
  • 6Hasle H,Niemeyer CM,Chessells JM,et al.A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases[J].Leukemia,2003,17(2):277-282.
  • 7Woods WG,Bernard DR,Alonzo TA,et al.Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome:a report from the Children's Cancer Group[J].J Clin Oncol,2002,20:434-440.
  • 8Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France : IARC Press ,2008 : 18-30.
  • 9Stachurski D, Smith BR, Pozdnyakova O, et al. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases:emphasis on a global evaluation and recognition of diagnostic pitfalls. Leuk Res,2008, 32:215-224.
  • 10Wang SA, Galili N, Cerny J, et al. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. Am J of Clin Pathol ,2006 ,126 :789-797.

引证文献9

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部